Brown Christopher D. 4
4 · 908 Devices Inc. · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
908 Devices (MASS) Director Christopher D. Brown Sells 2,200 Shares
What Happened
- Christopher D. Brown, a director of 908 Devices, sold 2,200 shares on July 2, 2026. The weighted average price reported was $9.02 per share, for total proceeds of approximately $19,844. The shares were sold in multiple transactions at prices ranging from $9.00 to $9.07.
Key Details
- Transaction date: 2026-07-02 (reported on Form 4 filed 2026-07-07)
- Price: weighted average $9.02; individual trade prices ranged $9.00–$9.07
- Shares sold: 2,200; proceeds ≈ $19,844
- Shares owned after the transaction: not provided in the information you supplied
- Footnotes: (F1) Sale was made pursuant to a Rule 10b5-1 trading plan adopted Nov 24, 2025. (F2) Reported price is a weighted average; detailed per-trade prices can be provided on request.
- Filing timeliness: Form 4 filed July 7, 2026. This appears to be within the standard two-business-day reporting window given the July 3–5 holiday/weekend period.
Context
- The sale was executed under a pre-arranged 10b5-1 plan, which typically means the trades were scheduled in advance and may not reflect the insider’s current view of the company. Sales are common for liquidity or diversification reasons; by contrast, new purchases are often watched more closely by investors as potential signals.
Insider Transaction Report
Form 4
908 Devices Inc.MASS
Brown Christopher D.
Director
Transactions
- Sale
Common Stock
[F1][F2]2026-07-02$9.02/sh−2,200$19,844→ 843,359 total
Footnotes (2)
- [F1]This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 24, 2025.
- [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.00 to $9.07 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Mark S. Levine, Attorney-in-Fact|2026-07-07